The Middle East and Africa neonatal jaundice management market size was valued at USD 95.37 Million in 2025 and is expected to reach USD 166.32 Million by 2033, at a CAGR of 7.20% during the forecast period
The market growth is largely fueled by the rising incidence of neonatal jaundice, increasing awareness among healthcare professionals and parents, and continuous technological advancements in phototherapy systems, leading to improved diagnosis, monitoring, and treatment outcomes across hospitals and neonatal care units.
Furthermore, growing demand for safe, non-invasive, and effective jaundice management solutions, along with expanding neonatal intensive care infrastructure and supportive government initiatives for maternal and child health, is accelerating the adoption of neonatal jaundice management technologies, thereby significantly boosting the overall market growth.
